OXY Stock - Occidental Petroleum Corporation

As of February 2026, Occidental Petroleum (OXY) has significantly accelerated its deleveraging timeline following the integration of CrownRock. While the company initially targeted a $4.5B short-term debt reduction within 12 months of the CrownRock closing, this milestone was achieved ahead of schedule in Q4 2024.

In the first half of 2026, Occidental’s priority has shifted toward a more ambitious medium-term target: reducing principal debt to below $15B. This effort is underpinned by the massive liquidity injection from the OxyChem divestiture and strategic shifts in midstream contract structures to insulate cash flow from Permian Basin pricing volatility.

Strategic Debt Repayment & Liquidity Management

The cornerstone of Occidental’s H1 2026 financial strategy is the deployment of proceeds from the sale of its chemical division, OxyChem, to Berkshire Hathaway.

• OxyChem Divestiture: On January 2, 2026, Occidental finalized the sale of OxyChem for $9.7B in cash. These proceeds are being prioritized for the retirement of high-interest debt and near-term maturities, effectively bypassing the need for organic free cash flow (FCF) to carry the entire deleveraging burden.
• Cumulative Progress: By mid-2025, the company had already repaid $7.5B in debt since the CrownRock acquisition. The current H1 2026 focus is on clearing the remaining path to the $15B floor, which management views as the threshold for resuming large-scale share repurchases and potentially redeeming Berkshire Hathaway’s preferred equity.

Mitigating Permian Midstream Volatility

Occidental has proactively restructured its midstream exposure to protect the cash flow required for debt servicing against the "Waha hub" pricing volatility that frequently plagues the Permian Basin.

• Fixed-Fee Transition: In January 2026, Occidental and Western Midstream (WES) amended their Delaware Basin gathering and processing contracts. By shifting to a fixed-fee structure, OXY has reduced its exposure to percent-of-proceeds (POP) fluctuations. This provides higher visibility into midstream costs even when Permian natural gas prices trade at a discount or turn negative.
• Flow Assurance: The integration of CrownRock assets included significant midstream infrastructure, which OXY has partially monetized (e.g., the $580M sale of Midland Basin gas gathering assets to Enterprise Products Partners) while maintaining firm transport agreements to ensure production reaches higher-value Gulf Coast markets.

Operational Discipline and Capital Allocation

To ensure debt reduction remains the primary use of cash in H1 2026, Occidental has adjusted its operational footprint and spending:

• Capex Reduction: Management has guided for a lower 2026 capital expenditure range of $6.3B – $6.7B, down from the $7.1B – $7.3B range seen in 2025. This reduction reflects a transition from "integration-heavy" spending to "maintenance and optimization" mode.
• Production Efficiency: Despite lower spending, OXY continues to leverage CrownRock’s high-margin inventory, maintaining total company production near 1.4 million BOE/d. Enhanced operational efficiencies, including AI-driven "ruthless operations" in the Permian, have lowered domestic operating costs to approximately $8.55 per barrel.

Risks and Uncertainties

• Commodity Price Sensitivity: While the OxyChem sale provides a massive cash buffer, a sustained drop in WTI prices below $60/bbl could slow the pace of additional FCF-based debt retirement.
• Environmental Liabilities: Following the OxyChem sale, OXY retained legacy environmental and tort liabilities. While these are long-term in nature, any acceleration in required remediation spending could impact short-term liquidity.
• Midstream Constraints: Despite fixed-fee contracts, extreme physical takeaway constraints in the Permian could still force production curtailments, impacting the top-line revenue used to fund the broader capital allocation strategy.

Occidental Petroleum’s (OXY) Stratos facility, the world’s first industrial-scale Direct Air Capture (DAC) plant, represents the cornerstone of its Low Carbon Ventures (LCV) segment. As the project moves toward its mid-2026 operational ramp-up, institutional capital allocation is increasingly contingent on the facility’s ability to demonstrate "bankability" through specific project-level EBITDA margins and cost-reduction milestones.

Project-Level Economics & EBITDA Margin Projections

The justification for further institutional capital relies on Stratos achieving a margin profile that competes with OXY’s high-return Permian upstream assets. Based on management’s disclosures and project cost structures, the expected project-level EBITDA margins for Stratos are derived from the following metrics:

• Revenue per Ton: OXY expects to generate between $580 and $810 per ton of captured $CO_2$. This revenue is a composite of voluntary carbon removal credits (CDR) and federal tax incentives.
• Operating Costs (OpEx): Initial capture costs are projected between $400 and $500 per ton. OXY aims to reduce these costs to <$100 per ton by 2050 through modular scaling and technology integration from its Carbon Engineering acquisition.
• Implied EBITDA Margin: At the mid-2026 ramp-up, the project-level EBITDA margin is expected to range from 15% to 35%.
  • Lower Bound: High OpEx ($500/t) and conservative credit pricing ($580/t) yields a ~13.8% margin.
  • Upper Bound: Optimized OpEx ($400/t) and premium credit pricing ($810/t) yields a ~50.6% margin.

Institutional Capital Catalysts & Hurdle Rates

For institutional investors like BlackRock—which has already committed $550M (approximately 40% of the $1.3B project cost)—further allocation depends on three primary financial "proof points":

1. Contractual Floor Price Validation: OXY has pre-sold 65% to 75% of Stratos’ capacity through 2030 to blue-chip offtakers (e.g., Amazon, Airbus, Microsoft). Institutional confidence requires these contracts to translate into a stable, "bankable" cash flow stream that mitigates the "asymmetric risk" of nascent technology.
2. 45Q Tax Credit Integrity: The Inflation Reduction Act (IRA) and subsequent 2025 legislative updates (e.g., the "One Big Beautiful Bill") provide a $180/ton credit for sequestered $CO_2$. This subsidy acts as a synthetic "floor" for EBITDA, ensuring the project remains cash-flow positive even if voluntary credit markets soften.
3. Capital Intensity Reduction: Stratos is designed to capture 500,000 metric tons annually. Institutional capital will follow if OXY can demonstrate a path to the South Texas DAC Hub, which targets a 1M+ ton capacity with lower per-unit CapEx.

Strategic Financial Integration

OXY’s management has signaled that the LCV segment is intended to eventually match the scale and margin profile of its OxyChem division.

• FCF Contribution: By 2H 2026, OXY expects an incremental $1B in annual Free Cash Flow (FCF) from non-oil and gas sources, including LCV and midstream enhancements.
• Deleveraging Synergy: The successful ramp-up of Stratos supports OXY’s goal of reducing principal debt to below $15B, as the LCV segment transitions from a capital-intensive "build" phase to a cash-generative "operate" phase.

Risks and Uncertainties

• Operational Execution: Stratos is 100x larger than any existing DAC facility; any mechanical failure or lower-than-expected capture efficiency would severely compress margins.
• Regulatory Dependency: A significant portion of the EBITDA margin is tied to federal tax credits. Any shift in U.S. climate policy or credit eligibility could jeopardize the project's internal rate of return (IRR).
• Voluntary Market Volatility: While pre-sales are strong, the long-term price for CDR credits remains speculative and highly sensitive to corporate ESG budget cycles.

As of Q1 2026, Occidental Petroleum (OXY) has entered a pivotal phase of its capital allocation strategy. Following the successful integration of CrownRock and the transformative $9.7B cash sale of its OxyChem division to Berkshire Hathaway in January 2026, the company has achieved its long-standing objective of reducing principal debt below the $15B threshold.

This deleveraging milestone shifts the analytical focus toward the "shareholder return pathway," specifically the tension between resuming large-scale common stock repurchases and the mandatory redemption of Berkshire Hathaway’s remaining 8% preferred equity.

The Capital Allocation Framework in 2026

With the balance sheet now optimized—projected net debt stands at approximately $14.3B—OXY’s management is navigating a hierarchy of cash use that prioritizes high-cost capital elimination.

• Debt Maturity Management: Having utilized $6.5B of the OxyChem proceeds to retire near-term debt, OXY has significantly lowered its interest expense.
• The 8% Hurdle: The Berkshire preferred equity remains the most expensive layer of OXY’s capital stack. While the optional redemption at 105% of par does not trigger until 2029, the company’s distribution policy effectively dictates the pace of earlier redemptions.

The Preferred Redemption vs. Buyback Trade-off

The primary mechanism governing OXY’s Q1 2026 policy is the "Capital Return Threshold." Under the terms of the 2019 agreement, OXY is required to redeem preferred shares at 110% of par value if total distributions to common shareholders (dividends plus buybacks) exceed $4.00 per share on a trailing 12-month basis.

• The "Forced" Redemption Strategy: Management appears to be leaning toward a "forced" redemption model. By increasing the common dividend (recently hiked by 9%) and resuming opportunistic buybacks, OXY triggers the mandatory redemption. While this requires paying a 10% premium, it eliminates an 8% annual cash drain, which is viewed as a high-return internal investment.
• Buyback Resumption: Analysts anticipate the announcement of a multi-year share repurchase program during the Q4 2025 earnings call (scheduled for February 18, 2026). This program is expected to be sized to ensure the $4.00 threshold is met, thereby systematically retiring the preferred equity while simultaneously reducing the common share count.

Strategic Influence of Berkshire’s 30% Ownership

Berkshire Hathaway’s ownership stake, currently hovering between 28% and 29%, creates a unique technical ceiling for OXY’s buyback policy.

1. The Creeping Threshold: If OXY aggressively repurchases common stock, Berkshire’s percentage ownership will naturally rise even without further purchases by Warren Buffett. Crossing the 30% mark may trigger different regulatory or accounting treatments (such as the equity method of accounting for Berkshire).
2. The OxyChem Precedent: The sale of OxyChem to Berkshire in exchange for cash—rather than a direct swap for preferred shares—indicates that OXY prefers maintaining liquidity to manage its own redemption schedule. This suggests management wants to retain control over the timing of shareholder returns rather than being dictated by a fixed swap agreement.

Risks and Macroeconomic Sensitivities

The primary risk to this capital allocation pivot is commodity price volatility. OXY’s ability to fund both the 110% preferred redemption premium and common buybacks depends on sustained Free Cash Flow (FCF).

• Oil Price Sensitivity: OXY remains highly leveraged to crude prices, though its breakeven has dropped below $50/bbl WTI.
• Natural Gas Upside: Higher realized gas prices in late 2025 have provided a buffer, but any significant downturn in Brent (forecasted by some to average $56/bbl in 2026) could force a slowdown in the pace of preferred redemptions to protect the common dividend.

In summary, OXY’s Q1 2026 policy is likely to be a "dual-track" return: using buybacks as the primary tool to return value to common holders while simultaneously using those same buybacks to trigger the retirement of the expensive Berkshire preferred equity.